EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Real‐World Clinical Impact of High‐Sensitivity Troponin for Chest Pain Evaluation in the Emergency Department

Jacob A Martin iD, Robert S Zhang iD, Aaron J Rhee iD, Archana Saxena, Olumide Akindutire iD, M Haisum Maqsood iD, Nicholas Genes iD, Nathan Gollogly, Nathaniel R Smilowitz iD, Adriana Quinones-Camacho iD

Journal of the American Heart Association · 20.05.2025 · 14 (10)

DOI: 10.1161/jaha.124.039322 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 20.05.2025. Verfasst von Jacob A Martin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine New York University New York NY. Hauptthemen laut MEDLINE: Emergency Service, Hospital, Troponin I, Chest Pain, Myocardial Infarction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High‐sensitivity cardiac troponin (hs‐cTnI) assays can quantify troponin concentrations with low limits of detection, potentially expediting and enhancing myocardial infarction diagnoses. This study investigates the real‐world impact of hs‐cTnI implementation on operational metrics and downstream cardiac services in patients presenting to the emergency department with chest pain. Methods and Results We conducted a retrospective study of patients who presented to 3 emergency departments for chest pain and in whom ≥1 troponin concentration was measured. We compared outcomes from January 2021 to March 2022 (conventional cardiac troponin I [cTnI]) against outcomes from April 2022 to March 2023 (post‐hs‐cTnI implementation). The primary outcome was hospital length of stay. The study included 32 076 emergency department patient‐visits (17 267 with cTnI, 14 809 with hs‐cTnI). Implementation of hs‐cTnI was associated with shorter median total length of stay (6.6 versus 6.0 hours, P [lt]0.001), shorter emergency department length of stay (5.5 versus 5.4 hours, P =0.039), and lower admission rates (32.6% versus 38.2%, adjusted odds ratio [aOR], 0.74 [95% CI, 0.69–0.79]; P [lt]0.0001). Hs‐cTnI was also associated with lower odds of cardiology consultation (aOR, 0.91 [95% CI, 0.86–0.97]; P =0.004), echocardiography (aOR, 0.86 [95% CI, 0.82–0.91]; P [lt]0.001), stress tests (aOR, 0.74 [95% CI, 0.67–0.81]; P [lt]0.001), and invasive coronary angiography (aOR, 0.77 [95% CI, 0.70–0.83]; P [lt]0.001), but greater odds of computed tomography coronary angiography (aOR, 1.26 [95% CI, 1.01–1.56]; P =0.03) and percutaneous coronary intervention (aOR, 1.40 [95% CI, 1.20–1.63]; P [lt] 0.001) during the index encounter.

Conclusion

Implementation of the hs‐cTnI assay was associated with reduced hospital admissions, shorter length of stay, and decreases in most downstream cardiac testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Emergency Service, HospitalTroponin IChest PainMyocardial InfarctionHumansFemaleMaleRetrospective StudiesMiddle AgedLength of StayBiomarkersAgedPredictive Value of Tests

Stichwörter der Autor:innen

chest painemergency departmenthigh‐sensitivitytroponin

Substanzen

Troponin IBiomarkers

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine New York University New York NY.
  • Department of Health Informatics NYU Grossman School of Medicine New York NY.
  • Division of Cardiology Weill Cornell Medicine New York NY.
  • Department of Medicine NYU Grossman School of Medicine New York NY.
  • Ronald O. Perelman Department of Emergency Medicine NYU Grossman School of Medicine New York NY.
  • Department of Cardiology, DeBakey Heart and Vascular Center Houston Methodist Hospital Houston TX.

ORCID-Profile: Jacob A Martin, Robert S Zhang, Aaron J Rhee, Olumide Akindutire, M Haisum Maqsood, Nicholas Genes, Nathaniel R Smilowitz, Adriana Quinones-Camacho

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Martin, J. A., Zhang, R. S., Rhee, A. J., Saxena, A., Akindutire, O., Maqsood, M. H., Genes, N., Gollogly, N., Smilowitz, N. R., & Quinones-Camacho, A. (2025). Real‐World Clinical Impact of High‐Sensitivity Troponin for Chest Pain Evaluation in the Emergency Department. Journal of the American Heart Association, 14(10). https://doi.org/10.1161/jaha.124.039322

Vancouver

Martin JA, Zhang RS, Rhee AJ, Saxena A, Akindutire O, Maqsood MH, et al. Real‐World Clinical Impact of High‐Sensitivity Troponin for Chest Pain Evaluation in the Emergency Department. Journal of the American Heart Association. 2025;14(10). doi:10.1161/jaha.124.039322

BibTeX
@article{Martin2025,
  author = {Martin, Jacob A and Zhang, Robert S and Rhee, Aaron J and Saxena, Archana and Akindutire, Olumide and Maqsood, M Haisum and Genes, Nicholas and Gollogly, Nathan and Smilowitz, Nathaniel R and Quinones-Camacho, Adriana},
  title = {Real‐World Clinical Impact of High‐Sensitivity Troponin for Chest Pain Evaluation in the Emergency Department},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {10},
  doi = {10.1161/jaha.124.039322}
}
Kostenlos starten →